Crospovidone Induced Vasculopathy of the Skin

Main Article Content

Brian James Simmons
Dartmouth Hitchcock Medical Center Section of Dermatology Department of Surgery 18 Old Etna Rd Lebanon, NH 03766

Brian S Hoyt
Dartmouth Hitchcock Medical Center Department of Pathology 1 Medical Center Dr. Lebanon, NH 03756

Konstantinos Linos
Dartmouth Hitchcock Medical Center Department of Pathology 1 Medical Center Dr. Lebanon, NH 03756

Shaofeng Yan
Dartmouth Hitchcock Medical Center Department of Pathology 1 Medical Center Dr. Lebanon, NH 03756

Kathryn A Zug
1Dartmouth Hitchcock Medical Center Section of Dermatology Department of Surgery 18 Old Etna Rd Lebanon, NH 03766

Keywords

Vasculopathy, intravenous Drug Use

Abstract

Not Applicable

References

1. Mathis SM, Hagemeier N, Hagaman A, Dreyzehner J, Pack RP. A Dissemination and Implementation Science Approach to the Epidemic of Opioid Use Disorder in the United States. Curr HIV/AIDS Rep. 2018.

2. Ganesan S, Felo J, Saldana M, Kalasinsky VF, Lewin-Smith MR, Tomashefski JF, Jr. Embolized crospovidone (poly[N-vinyl-2-pyrrolidone]) in the lungs of intravenous drug users. Mod Pathol. 2003;16(4):286-292.

3. Shaddy SM, Arnold MA, Shilo K, et al. Crospovidone and Microcrystalline Cellulose: A Novel Description of Pharmaceutical Fillers in the Gastrointestinal Tract. Am J Surg Pathol. 2017;41(4):564-569.

Article Sidebar

Full Article PDF
Published
Sep 13, 2019
DOI https://doi.org/10.25251/skin.3.5.10

Article Details

How to Cite
Simmons, B. J., Hoyt, B. S., Linos, K., Yan, S., & Zug, K. A. (2019). Crospovidone Induced Vasculopathy of the Skin. SKIN The Journal of Cutaneous Medicine, 3(5), 348–349. https://doi.org/10.25251/skin.3.5.10
Issue
Vol. 3 No. 5 (2019)
Section
Brief Articles
Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

All authors retain copyright in their articles. All articles published open access allowing for immediate free access to the work and permitting any user to read, download, copy, distribute, print, search, or link to the full texts of articles, crawl them for indexing, pass them as data to software or use them for any other lawful purpose. Permitted reuse is defined by  the following user license:
 

Creative Commons Attribution (CC BY): lets others distribute and copy the article, to create extracts, abstracts, and other revised versions, adaptations or derivative works of or from an article (such as a translation), to include in a collective work (such as an anthology), to text or data mine the article, even for commercial purposes, as long as they credit the author(s), do not represent the author as endorsing their adaptation of the article, and do not modify the article in such a way as to damage the author's honor or reputation. 

Authors retain copyright in their work and license the publisher to publish the content. The publisher is the National Society for Cutaneous Medicine, with production and publishing support provided by OJS, Open Journal Systems,see https://pkp.sfu.ca/ojs/.

Prior to January 2022, authors transferred copyright to the National Society for Cutaneous Medicine. However, all articles are freely available to anyone in the world. There are no subscription fees, page charges, or article processing charges.